Previous 10 | Next 10 |
Hoth Therapeutics Announces its HT-003 Shows Positive Initial Data Inhibiting Toll-like Receptor 2 (TLR2) Initial data reports one of the most critical genes for acne pathophysiology, toll-like receptor 2 (TLR2), is significantly inhibited by HT-003 PR Newswire NEW YORK,...
Presentation Times and Weblinks Released for Over 150 Presenting Companies Day 1: Wednesday, September 23, 2020 ALL INSTITUTIONAL AND RETAIL INVESTORS ARE WELCOME NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Sidoti & Company, LLC has released the presentation schedule,...
Hoth Therapeutics ([[HOTH]] -3.8%) has entered into a research agreement with the George Washington University, related to the development of an in vitro diagnostic device that allows immediate detection of SARS-CoV-2 via a mobile device.Nanohole array-based device utilizes plasmoni...
Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device Company will Partner with the George Washington University on R&D for their Licensed Smartphone-Based Direct Virus Sensing System PR Newswire NEW YORK, Sept. 21, 2020 ...
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global pharmaceutical contract development and manufacturing organization. The agreement partners Voltron with a multi-nati...
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today the successful completion of its previously announced first small animal safety and immunogenicity study assessing the effect of novel Covid-19 vaccine HaloVax™. The vaccine construct was ad...
NEW YORK , Sept. 1 , 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced Dr. Stefanie Johns , who has agreed to join Hoth and serve as its Chief Scientific Officer, is scheduled to appear as a featured guest on On...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
Hoth Therapeutics (NASDAQ: HOTH ) appoints of Stefanie Johns, Ph.D., to the position of Chief Scientific Officer, effective September 2020. More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...
NEW YORK , Aug. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announces the appointment of Stefanie Johns, Ph.D., to the position of Chief Scientific Officer, effective September 2020 . In her role, Dr. Johns will f...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NASDAQ Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...